INS and metabolic dysfunction-associated steatohepatitis: Since diabetes is caused by decreased insulin action in various tissues, impaired insulin action in the liver or other tissues may lead to carcinogenesis supported by driver mutations in STAM mice and in patients with diabetes and NASH.